ASMA KHAPRA
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology FAIRFAX, VA NPI 1770702011
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology VA Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$23,946.59
- Category: General Payments
- Program years: PY2018–2024
- Record count: 413
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $7,118.91 across 72 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,170.00 | 2 |
| Food and Beverage | $1,895.75 | 67 |
| Education | $53.16 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $4,638.61 | 11 |
| Ardelyx, Inc. | $1,000.00 | 1 |
| ABBVIE INC. | $370.09 | 23 |
| Regeneron Healthcare Solutions, Inc. | $211.82 | 3 |
| Janssen Research & Development, LLC | $122.38 | 1 |
| Celgene Corporation | $81.05 | 4 |
| PFIZER INC. | $78.67 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $76.27 | 4 |
| Medtronic, Inc. | $64.71 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $58.79 | 3 |
| Phathom Pharmaceuticals, Inc. | $53.44 | 3 |
| Celltrion USA Inc. | $53.16 | 3 |
| Echosens North America, Inc. | $53.00 | 1 |
| Ipsen Biopharmaceuticals, Inc | $51.16 | 2 |
| GENZYME CORPORATION | $49.80 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $34.16 | 1 |
| Lilly USA, LLC | $33.74 | 1 |
| Gilead Sciences, Inc. | $31.75 | 2 |
| Madrigal Pharmaceuticals | $23.32 | 1 |
| Braintree Laboratories, Inc. | $17.95 | 1 |
| CapsoVision, Inc. | $15.04 | 1 |
By program year
Records — PY2024 (72)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.